Breo Ellipta

List of products in the National Drug Code with proprietary name breo ellipta. This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0173-0859Breo Ellipta Fluticasone Furoate And Vilanterol TrifenatatePowderRespiratory (inhalation)Glaxosmithkline LlcHuman Prescription Drug
0173-0882Breo Ellipta Fluticasone Furoate And Vilanterol TrifenatatePowderRespiratory (inhalation)Glaxosmithkline LlcHuman Prescription Drug
0173-0916Breo Ellipta Fluticasone Furoate And Vilanterol TrifenatatePowderRespiratory (inhalation)Glaxosmithkline LlcHuman Prescription Drug
50090-2404Breo Ellipta A-s Medication Solutions